Jump Financial’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,125
Closed -$78.9K 2071
2025
Q4
$78.9K Buy
29,125
+3,412
+13% +$11.2K ﹤0.01% 1845
2025
Q3
$109K Buy
25,713
+13,662
+113% +$60.1K ﹤0.01% 1683
2025
Q2
$60K Buy
12,051
+920
+8% +$4K ﹤0.01% 1675
2025
Q1
$49.1K Buy
+11,131
New +$52.2K ﹤0.01% 1521
2024
Q2
Sell
-53,600
Closed -$381K 1960
2024
Q1
$381K Sell
53,600
-93,411
-64% -$618K 0.01% 1323
2023
Q4
$985K Buy
147,011
+125,028
+569% +$704K 0.03% 731
2023
Q3
$124K Sell
21,983
-37,382
-63% -$249K ﹤0.01% 1641
2023
Q2
$328K Buy
+59,365
New +$319K 0.01% 1263
2023
Q1
Sell
-69,061
Closed -$322K 1753
2022
Q4
$322K Sell
69,061
-23,212
-25% -$114K 0.02% 992
2022
Q3
$431K Buy
92,273
+12,420
+16% +$78.3K 0.02% 959
2022
Q2
$472K Buy
+79,853
New +$889K 0.02% 879
2022
Q1
Sell
-49,434
Closed -$1.61M 1671
2021
Q4
$1.61M Buy
+49,434
New +$1.99M 0.1% 258
2021
Q3
Sell
-6,100
Closed -$220K 1224
2021
Q2
$220K Buy
+6,100
New +$225K 0.02% 813

Other funds holding GDRX

Jump Financial's GDRX Position: Q1 2026 in Review

Jump Financial sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 29,125 shares — an estimated $78.9K sold.

Jump Financial first reported a position in GDRX in Q2 2021 and held it in 13 quarters. The position peaked at $1.61M in Q4 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Jump Financial reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 29,125 GoodRx Holdings shares in Q1 2026, an estimated $78.9K.
  • Jump Financial first reported a position in GoodRx Holdings in Q2 2021 and held it in 13 quarters.
  • Jump Financial's GoodRx Holdings position peaked at $1.61M in Q4 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.